title: Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
authors.forename: Lukás
authors.initials: L
authors.lastname: Smolej
authors.forename: David
authors.initials: D
authors.lastname: Belada
authors.forename: Melanie
authors.initials: M
authors.lastname: Cermanová
authors.forename: Vladimír
authors.initials: V
authors.lastname: Maisnar
authors.forename: Eva
authors.initials: E
authors.lastname: Lunáková
mesh_terms: D000368:Aged; D000743:Anemia, Hemolytic / Q000150:complications / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D002699:Chlorambucil; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone